These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10217432)

  • 1. Implication of proteasome in estrogen receptor degradation.
    El Khissiin A; Leclercq G
    FEBS Lett; 1999 Apr; 448(1):160-6. PubMed ID: 10217432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression.
    Kinyamu HK; Archer TK
    Mol Cell Biol; 2003 Aug; 23(16):5867-81. PubMed ID: 12897156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome-dependent degradation of the human estrogen receptor.
    Nawaz Z; Lonard DM; Dennis AP; Smith CL; O'Malley BW
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1858-62. PubMed ID: 10051559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells.
    El Khissiin A; Journé F; Laïos I; Seo HS; Leclercq G
    Steroids; 2000 Dec; 65(12):903-13. PubMed ID: 11077089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of proteasome-dependent estrogen receptor alpha and beta turnover in cultured human uterine artery endothelial cells.
    Tschugguel W; Dietrich W; Zhegu Z; Stonek F; Kolbus A; Huber JC
    J Clin Endocrinol Metab; 2003 May; 88(5):2281-7. PubMed ID: 12727987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent.
    Stenoien DL; Patel K; Mancini MG; Dutertre M; Smith CL; O'Malley BW; Mancini MA
    Nat Cell Biol; 2001 Jan; 3(1):15-23. PubMed ID: 11146621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradation.
    Tsai HW; Katzenellenbogen JA; Katzenellenbogen BS; Shupnik MA
    Endocrinology; 2004 Jun; 145(6):2730-8. PubMed ID: 15033909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein synthesis is not implicated in the ligand-dependent activation of the estrogen receptor in MCF-7 cells.
    El Khissiin A; Cleeren A; Borràs M; Leclercq G
    J Steroid Biochem Mol Biol; 1997 Jul; 62(4):269-76. PubMed ID: 9408080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of suppressor for Gal 1 in the ubiquitin/proteasome-mediated degradation of estrogen receptors.
    Masuyama H; Hiramatsu Y
    J Biol Chem; 2004 Mar; 279(13):12020-6. PubMed ID: 14702340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression.
    Borrás M; Hardy L; Lempereur F; el Khissiin AH; Legros N; Gol-Winkler R; Leclercq G
    J Steroid Biochem Mol Biol; 1994 Mar; 48(4):325-36. PubMed ID: 8142311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between estrogen receptor alpha and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes.
    Wormke M; Stoner M; Saville B; Safe S
    FEBS Lett; 2000 Jul; 478(1-2):109-12. PubMed ID: 10922479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
    Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
    J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells.
    Morelli C; Garofalo C; Bartucci M; Surmacz E
    Oncogene; 2003 Jun; 22(26):4007-16. PubMed ID: 12821935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells.
    Qin C; Burghardt R; Smith R; Wormke M; Stewart J; Safe S
    Cancer Res; 2003 Mar; 63(5):958-64. PubMed ID: 12615709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation.
    Alarid ET; Bakopoulos N; Solodin N
    Mol Endocrinol; 1999 Sep; 13(9):1522-34. PubMed ID: 10478843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
    Wagenknecht B; Hermisson M; Eitel K; Weller M
    Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the proteasome in the regulation of estrogen receptor alpha turnover and function in MCF-7 breast carcinoma cells.
    Laïos I; Journé F; Nonclercq D; Vidal DS; Toillon RA; Laurent G; Leclercq G
    J Steroid Biochem Mol Biol; 2005 Mar; 94(4):347-59. PubMed ID: 15857754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome pathway operates for the degradation of ornithine decarboxylase in intact cells.
    Murakami Y; Tanahashi N; Tanaka K; Omura S; Hayashi S
    Biochem J; 1996 Jul; 317 ( Pt 1)(Pt 1):77-80. PubMed ID: 8694789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-activated platelet-derived growth factor beta-receptor is degraded through proteasome-dependent proteolytic pathway.
    Mori S; Kanaki H; Tanaka K; Morisaki N; Saito Y
    Biochem Biophys Res Commun; 1995 Dec; 217(1):224-9. PubMed ID: 8526915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.